The company is a high-tech biomedical enterprise focusing on R&D, production and sales of medical biomaterials. The company strategically focuses on rapidly growing treatment fields in the medical biomaterials market, including ophthalmology, plastic surgery and wound care, orthopedics, anti-adhesion and hemostasis. The Group is a technology-innovative enterprise engaged in R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. Main products: intraocular lenses, ophthalmic viscoelastic agents, corneal shaping lenses, PRL, hyaluronic acid, orthopedic joint cavity viscoelastic supplements, anti-adhesion and hemostasis, etc. The company has received honors such as the National Science and Technology Progress Award and the second prize of the National Science and Technology Progress Award.
No Data